tiprankstipranks
Shanghai Pharmaceuticals Holding Co Ltd Class H (SHPMF)
OTHER OTC:SHPMF

Shanghai Pharmaceuticals Holding Co (SHPMF) Stock Forecast & Price Target

10 Followers
See the Price Targets and Ratings of:

SHPMF Analyst Ratings

Currently, no data available
Based on 0 analysts giving stock ratings to
Shanghai
Pharmaceuticals Holding Co
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

SHPMF Stock 12 Month Forecast

There Are No Analyst Ratings for SHPMF In The Last 3 Months.
Highest Price TargetAverage Price TargetLowest Price Target
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

SHPMF Financial Forecast

SHPMF Earnings Forecast

Next quarter’s earnings estimate for SHPMF is $0.08 with a range of $0.08 to $0.08. The previous quarter’s EPS was $0.07. SHPMF beat its EPS estimate 25.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 57.29% of the time in the same period. In the last calendar year SHPMF has Underperformed its overall industry.
Next quarter’s earnings estimate for SHPMF is $0.08 with a range of $0.08 to $0.08. The previous quarter’s EPS was $0.07. SHPMF beat its EPS estimate 25.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 57.29% of the time in the same period. In the last calendar year SHPMF has Underperformed its overall industry.

SHPMF Sales Forecast

The previous quarter’s earnings for SHPMF were $8.65B.
The previous quarter’s earnings for SHPMF were $8.65B.

Detailed List of Analyst Forecasts​

Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Morgan Stanley
$2.30
Buy
54.89%
Upside
Reiterated
12/21/23
Shanghai Pharmaceuticals Holdings (2607:HK) (FJLLF) PT Lowered to HK$18 at Morgan StanleyMorgan Stanley analyst Laurence Tam lowered the price target on Shanghai Pharmaceuticals Holdings (2607:HK) (OTC: FJLLF) to HK$18.00 (from HK$19.00) while maintaining a Overweight rating.
Goldman Sachs
$1.79
Sell
20.30%
Upside
Reiterated
10/30/23
Shanghai Pharmaceuticals Holdings (2607:HK) (FJLLF) PT Lowered to HK$13.98 at Goldman SachsGoldman Sachs analyst Ziyi Chen lowered the price target on Shanghai Pharmaceuticals Holdings (2607:HK) (OTC: FJLLF) to HK$13.98 (from HK$14.40) while maintaining a Sell rating.
Citi Analyst forecast on SHPMF
Unknown Analyst
Not Ranked
Citi
$2.24
Buy
50.58%
Upside
Reiterated
11/07/23
Shanghai Pharmaceuticals Holdings (2607:HK) (FJLLF) PT Lowered to HK$17.50 at CitiCiti analyst David Shang lowered the price target on Shanghai Pharmaceuticals Holdings (2607:HK) (OTC: FJLLF) to HK$17.50 (from HK$19.00) while maintaining a Buy rating.

Best Analysts Covering Shanghai Pharmaceuticals Holding Co

Which Analyst Should I Follow If I Want to Buy SHPMF and Sell After:
1 Month
Ziyi ChenGoldman Sachs
Success Rate
1/1 ratings generated profit
100%
Average Return
+7.30%
reiterated a sell rating 6 months ago
Copying Ziyi Chen's trades and holding each position for 1 Month would result in 100.00% of your transactions generating a profit, with an average return of +7.30% per trade.
dummydummy
Success Rate
0/0 ratings generated profit
0%
Average Return
0.00%
a rating ―
Copying dummy's trades and holding each position for XXXX would result in 0.10% of your transactions generating a profit, with an average return of 0.00% per trade.
Premium Content
Find out which analyst has the highest Average Return & Success Rate
Go Premium
3 Months
Laurence TamMorgan Stanley
Success Rate
1/1 ratings generated profit
100%
Average Return
+9.30%
reiterated a buy rating 5 months ago
Copying Laurence Tam's trades and holding each position for 3 Months would result in 100.00% of your transactions generating a profit, with an average return of +9.30% per trade.
dummydummy
Success Rate
0/0 ratings generated profit
0%
Average Return
0.00%
a rating ―
Copying dummy's trades and holding each position for XXXX would result in 0.10% of your transactions generating a profit, with an average return of 0.00% per trade.
Premium Content
Find out which analyst has the highest Average Return & Success Rate
Go Premium
1 Year
Laurence TamMorgan Stanley
Success Rate
1/1 ratings generated profit
100%
Average Return
+6.40%
reiterated a buy rating 5 months ago
Copying Laurence Tam's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +6.40% per trade.
2 Years
Laurence TamMorgan Stanley
Success Rate
1/1 ratings generated profit
100%
Average Return
+6.40%
reiterated a buy rating 5 months ago
Copying Laurence Tam's trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +6.40% per trade.
dummydummy
Success Rate
0/0 ratings generated profit
0%
Average Return
0.00%
a rating ―
Copying dummy's trades and holding each position for XXXX would result in 0.10% of your transactions generating a profit, with an average return of 0.00% per trade.
Premium Content
Find out which analyst has the highest Average Return & Success Rate
Go Premium
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

SHPMF Analyst Recommendation Trends

Rating
Apr 21
Oct 23
Nov 23
Dec 23
Strong Buy
0
0
1
2
Buy
0
0
0
0
Hold
1
1
1
0
Sell
0
1
1
1
Strong Sell
0
0
0
0
total
1
2
3
3
In the current month, SHPMF has received 2 Buy Ratings, 0 Hold Ratings, and 1 Sell Ratings. SHPMF average Analyst price target in the past 3 months is .
Each month's total comprises the sum of three months' worth of ratings.
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

SHPMF Stock Forecast FAQ

What is SHPMF’s average 12-month price target, according to analysts?
Currently, no data Available
What is SHPMF’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for SHPMF, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is SHPMF a Buy, Sell or Hold?
      Currently, no data Available
      What is Shanghai Pharmaceuticals Holding Co Ltd Class H’s price target?
      Currently, no data Available
      What do analysts say about Shanghai Pharmaceuticals Holding Co Ltd Class H?
      Not enough analysts have published a price target to provide an average price target.
      How can I buy shares of SHPMF?
      Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.
        What's Included in PREMIUM?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis